4/A

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: September 24, 2019
Period of Report: September 19, 2019
Accession Number: 0000886163-19-000177

View Document ↗ View on SEC.gov ↗